Core Viewpoint - Boston Scientific Corporation will host a conference call to discuss its financial results and business highlights for the second quarter of 2025 on July 23, 2025 [1] Group 1: Financial Results Announcement - The conference call will take place at 8:00 a.m. ET and will be led by the CEO Mike Mahoney and CFO Jon Monson [1] - A news release with the financial results will be issued prior to the conference call on the same day [1] Group 2: Webcast Information - A live webcast and replay of the event will be available at the company's investor relations website [2] - The replay will be accessible approximately one hour after the event concludes [2] Group 3: Company Overview - Boston Scientific is a global leader in medical technology, focusing on innovative solutions that improve patient health [3] - The company has been advancing medical science for over 45 years, providing a wide range of devices and therapies for various complex diseases [3]

Core Viewpoint - Boston Scientific Corporation has successfully completed a public offering of €1.5 billion in notes, which will be used for debt repayment and general corporate purposes [1][2]. Group 1: Offering Details - The company issued €850 million of 3.000% notes due in 2031 and €650 million of 3.250% notes due in 2034 [1]. - The notes are fully and unconditionally guaranteed by Boston Scientific [1]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized to repay AMS Europe's 0.750% senior notes maturing on March 8, 2025, and to cover accrued and unpaid interest on those notes [2]. - Additional uses of the proceeds may include short-term investments, reduction of short-term debt, funding of working capital, and potential future acquisitions [2]. Group 3: Company Overview - Boston Scientific is a global leader in medical technology, focusing on innovative solutions that improve patient health and reduce healthcare costs [3]. - The company has been advancing medical science for over 45 years, providing a wide range of devices and therapies for various complex diseases [3].